Journal of Kermanshah University of Medical Sciences

Published by: Kowsar

Antifungal Effects of Silybum marianum Extract Individually and in Combination with Fluconazole on Clinical Candida Isolates in Northern Iran

Leila Fozouni 1 , * and Mahdis Palang 1
Authors Information
1 Department of Biology, Gorgan Branch, Islamic Azad University, Gorgan, Iran
Article information
  • Journal of Kermanshah University of Medical Sciences: 22 (4); e84803
  • Published Online: December 26, 2018
  • Article Type: Research Article
  • Received: October 2, 2018
  • Revised: December 11, 2018
  • Accepted: December 16, 2018
  • DOI: 10.5812/jkums.84803

To Cite: Fozouni L, Palang M. Antifungal Effects of Silybum marianum Extract Individually and in Combination with Fluconazole on Clinical Candida Isolates in Northern Iran, J Kermanshah Univ Med Sci. Online ahead of Print ; 22(4):e84803. doi: 10.5812/jkums.84803.

Abstract
Copyright © 2018, Journal of Kermanshah University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Menon T, Umamaheswari K, Kumarasamy N, Solomon S, Thyagarajan SP. Efficacy of fluconazole and itraconazole in the treatment of oral candidiasis in HIV patients. Acta Trop. 2001;80(2):151-4. [PubMed: 11600094].
  • 2. Pappas PG, Kauffman CA, Andes D, Benjamin DK Jr, Calandra TF, Edwards JE Jr, et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the infectious diseases society of America. Clin Infect Dis. 2009;48(5):503-35. doi: 10.1086/596757. [PubMed: 19191635].
  • 3. Eftekhari AD, Anvari M, Ranji N. [Investigation of ERG11 gene mutations in fluconazole resistant Candida albicans isolated from a number of Rasht hospitals]. Pathobiol Res. 2015;18(3):98-107. Persian.
  • 4. Lahlah ZF, Meziani M, Maza A. Silymarin natural antimicrobial agent extracted from Silybum marianum. J Academia. 2012;2:164-9.
  • 5. Bibi Y, Nisa S, Chaudhary FM, Zia M. Antibacterial activity of some selected medicinal plants of Pakistan. BMC Complement Altern Med. 2011;11:52. doi: 10.1186/1472-6882-11-52. [PubMed: 21718504]. [PubMed Central: PMC3141602].
  • 6. Evren E, Yurtcu E. In vitro effects on biofilm viability and antibacterial and antiadherent activities of silymarin. Folia Microbiol (Praha). 2015;60(4):351-6. doi: 10.1007/s12223-015-0399-6. [PubMed: 25937395].
  • 7. Sanchez-Sampedro A, Kim HK, Choi YH, Verpoorte R, Corchete P. Metabolomic alterations in elicitor treated Silybum marianum suspension cultures monitored by nuclear magnetic resonance spectroscopy. J Biotechnol. 2007;130(2):133-42. doi: 10.1016/j.jbiotec.2007.03.007. [PubMed: 17475356].
  • 8. Saller R, Meier R, Brignoli R. The use of silymarin in the treatment of liver diseases. Drugs. 2001;61(14):2035-63. doi: 10.2165/00003495-200161140-00003. [PubMed: 11735632].
  • 9. Rex JH, Clinical ; Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of yeasts. 3rd ed. Pennsylvania: Clinical and Laboratory Standards Institute; 2008.
  • 10. Jabra-Rizk MA, Baqui AA, Kelley JI, Falkler WA Jr, Merz WG, Meiller TF. Identification of Candida dubliniensis in a prospective study of patients in the United States. J Clin Microbiol. 1999;37(2):321-6. [PubMed: 9889211]. [PubMed Central: PMC84296].
  • 11. Pfaller MA, Messer SA, Boyken L, Rice C, Tendolkar S, Hollis RJ, et al. Caspofungin activity against clinical isolates of fluconazole-resistant Candida. J Clin Microbiol. 2003;41(12):5729-31. [PubMed: 14662968]. [PubMed Central: PMC309007].
  • 12. Badiee P, Alborzi A, Shakiba E, Ziyaeyan M, Rasuli M. Molecular identification and in-vitro susceptibility of Candida albicans and C. dubliniensis isolated from immunocompromised patients. Iran Red Crescent Med J. 2009;11(4):391-7.
  • 13. Diba K, Chavoshin AR, Hoseyni Jazani N, Badie P, Bonyadi F, Alizadeh HR, et al. [Identification and determination of drog resictant of candida spesies isolated from hospital acquired infections]. Med Sci J. 2015;19(10):870-82. Persian.
  • 14. Matar MJ, Ostrosky-Zeichner L, Paetznick VL, Rodriguez JR, Chen E, Rex JH. Correlation between E-test, disk diffusion, and microdilution methods for antifungal susceptibility testing of fluconazole and voriconazole. Antimicrob Agents Chemother. 2003;47(5):1647-51. [PubMed: 12709335]. [PubMed Central: PMC153338].
  • 15. Kabli SA. In vitro susceptibilities of clinical yeast isolates to antifungal drugs of polyene, pyrimidine, and azoles, and their effect in yeast adhesion and mycelial formation. Saudi J Biol Sci. 2008;15(2):189-98.
  • 16. Bagg J, Sweeney MP, Lewis MA, Jackson MS, Coleman D, Al MA, et al. High prevalence of non-albicans yeasts and detection of anti-fungal resistance in the oral flora of patients with advanced cancer. Palliat Med. 2003;17(6):477-81. doi: 10.1191/0269216303pm793oa. [PubMed: 14526879].
  • 17. Laverdiere M. In vitro activity of three new triazoles and one echinocandin against Candida bloodstream isolates from cancer patients. J Antimicrob Chemotherap. 2002;50(1):119-23. doi: 10.1093/jac/dkf074.
  • 18. Xiao M, Fan X, Chen SC, Wang H, Sun ZY, Liao K, et al. Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance. J Antimicrob Chemother. 2015;70(3):802-10. doi: 10.1093/jac/dku460. [PubMed: 25473027].
  • 19. Manohar V, Ingram C, Gray J, Talpur NA, Echard BW, Bagchi D, et al. Antifungal activities of origanum oil against Candida albicans. Mol Cell Biochem. 2001;228(1-2):111-7. [PubMed: 11855736].
  • 20. Zheng W, Wang SY. Antioxidant activity and phenolic compounds in selected herbs. J Agric Food Chem. 2001;49(11):5165-70. [PubMed: 11714298].
  • 21. Karaman S, Digrak M, Ravid U, Ilcim A. Antibacterial and antifungal activity of the essential oils of thymus revolutus celak from Turkey. J Ethnopharmacol. 2001;76(2):183-6. [PubMed: 11390134].
  • 22. Trakranrungsie N, Chatchawanchonteera A, Khunkitti W. Ethnoveterinary study for antidermatophytic activity of Piper betle, Alpinia galanga and Allium ascalonicum extracts in vitro. Res Vet Sci. 2008;84(1):80-4. doi: 10.1016/j.rvsc.2007.03.006. [PubMed: 17482221].
  • 23. Natarajan V, Venugopal PV, Menon T. Effect of Azadirachta indica (neem) on the growth pattern of dermatophytes. Indian J Med Microbiol. 2003;21(2):98-101. [PubMed: 17642990].
  • 24. Shams Ghahfarokhi M, Razafsha M, Allameh A, Razzaghi Abyaneh M. Inhibitory effects of aqueous onion and garlic extracts on growth and keratinase activity in Trichophyton mentagrophytes. Iran Biomed J. 2003;7(3):113-8.
  • 25. Song JL, Lyons CN, Holleman S, Oliver BG, White TC. Antifungal activity of fluconazole in combination with lovastatin and their effects on gene expression in the ergosterol and prenylation pathways in Candida albicans. Med Mycol. 2003;41(5):417-25. [PubMed: 14653518].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments